Jennifer K. Simpson's Insider Trades & SAST Disclosures
Jennifer K. Simpson's most recent trade in Panbela Therapeutics Inc. was a trade of 72,800 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jennifer K. Simpson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Panbela Therapeutics Inc. | Jennifer K Simpson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 72,800 | 72,800 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Jennifer K Simpson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 99,383 | 99,383 | - | - | Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Jennifer K Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 16,253 | 16,253 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Jennifer K Simpson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jan 2023 | 8,888 | 8,888 | - | - | Warrants (right to buy) | |
| Panbela Therapeutics Inc. | Jennifer K Simpson | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jan 2023 | 4,444 | 7,868 (0%) | 0% | - | Common Stock | |
| Eagle Pharmaceuticals Inc | Jennifer K Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 11,200 | 11,200 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Jennifer K Simpson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2021 | 19,125 | 19,125 | - | - | Employee Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Jennifer K Simpson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 170,000 | 170,000 | - | - | Employee Stock Option (right to buy) | |
| Eagle Pharmaceuticals Inc | Jennifer K Simpson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| Delcath Systems Inc | Jennifer K Simpson | Director, President and CEO | 06 May 2020 | 14,700 | 25,021 (0%) | 0% | - | Common Stock | ||
| Delcath Systems Inc | Jennifer K Simpson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 10,310 | 10,321 (0%) | 0% | 0 | Common Stock | |
| Delcath Systems Inc | Jennifer K Simpson | Director, President and CEO | 06 May 2020 | 147 | 0 | - | - | Series E Convertible Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges